PEGylation of Neuromedin U yields a promising candidate for the treatment of obesity and diabetes-Reference-Cited by-同舟云学术

PEGylation of Neuromedin U yields a promising candidate for the treatment of obesity and diabetes

Published:2012-08 Issue:15 Volume:20 Page:4751-4759
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Ingallinella Paolo,Peier Andrea M.,Pocai Alessandro,Marco Annalise Di,Desai Kunal,Zytko Karolina,Qian Ying,Du Xiaobing,Cellucci Antonella,Monteagudo Edith,Laufer Ralph,Bianchi Elisabetta,Marsh Donald J.,Pessi Antonello

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference51 articles.

1. Gut Peptides: Targets for Antiobesity Drug Development?

2. The role of gut hormones in the regulation of body weight and energy homeostasis

3. Therapeutic Potential of Gut Peptides

4. Neuromedin U and Its Receptors: Structure, Function, and Physiological Roles

5. Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of a Pentapeptide Antagonist to Human Neuromedin U Receptor 1;ACS Medicinal Chemistry Letters;2024-05-24

2. Suppressive Effects of Neuromedin U Receptor 2-Selective Peptide Agonists on Appetite and Prolactin Secretion in Mice;ACS Medicinal Chemistry Letters;2024-02-14

3. The neuromedin U system: Pharmacological implications for the treatment of obesity and binge eating behavior;Pharmacological Research;2023-09

4. Bioinformatics and Next-Generation Data Analysis for Identification of Genes and Molecular Pathways Involved in Subjects with Diabetes and Obesity;Medicina;2023-02-07

5. Regulation of feeding and therapeutic application of bioactive peptides;Pharmacology & Therapeutics;2022-11